MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Genetic risk scores and hallucinations in Parkinson’s disease patients

C. Kusters, K. Paul, A. Duarte Folle, A. Keener, J. Bronstein, V. Dobricic, O.B Tysnes, L. Bertram, G. Alves, J. Sinsheimer, C. Lill, J. Maple-Grødem, B. Ritz (Los Angeles, CA, USA)

Meeting: MDS Virtual Congress 2020

Abstract Number: 482

Keywords: Hallucinations

Category: Parkinson's Disease: Genetics

Objective: To examine the overlap of genetic architecture for Alzheimer’s disease (AD), schizophrenia (SZ), and PD with the genetic architecture for the occurrence of hallucinations in PD.

Background: Non-motor symptoms, such as hallucinations, among Parkinson’s disease (PD) patients are common. However, the genetic risk factors for hallucinations in PD remain largely elusive.

Method: We used two population-based studies (ParkWest, Norway, and PEG, USA) providing us with 399 PD patients with European ancestry and with a PD diagnosis after age 55 to assess the associations between four polygenic risk scores (PRS) and hallucinations after five years of mean disease duration. Based on existing GWAS of other cohorts, four PRS were created: one each using AD, SZ, and PD cohorts and another PRS for height, which served as a negative control.

Results: A higher prevalence of hallucinations was observed with each standard deviation increase of the AD-PRS (OR: 1.37, 95%CI: 1.03-1.83; P-value 0.03). This effect was mainly driven by APOE (OR: 1.92, 95%CI: 1.14-3.22; P-value 0.01). In addition, a suggestive decrease and increase, respectively, in hallucinations prevalence was observed with the SZ-PRS and the PD-PRS (OR: 0.77, 95%CI: 0.59-1.01; P-value 0.06; and OR: 1.29, 95%CI: 0.95-1.76; P-value 0.11, respectively). No association was observed with the height PRS (OR: 1.00, 95%CI: 0.74-1.35; P-value 0.98).

Conclusion: These results suggest that mechanisms for hallucinations in PD may be driven by the some of the same genetic architecture that leads to cognitive decline in AD, especially by APOE.

To cite this abstract in AMA style:

C. Kusters, K. Paul, A. Duarte Folle, A. Keener, J. Bronstein, V. Dobricic, O.B Tysnes, L. Bertram, G. Alves, J. Sinsheimer, C. Lill, J. Maple-Grødem, B. Ritz. Genetic risk scores and hallucinations in Parkinson’s disease patients [abstract]. Mov Disord. 2020; 35 (suppl 1). https://www.mdsabstracts.org/abstract/genetic-risk-scores-and-hallucinations-in-parkinsons-disease-patients/. Accessed May 21, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to MDS Virtual Congress 2020

MDS Abstracts - https://www.mdsabstracts.org/abstract/genetic-risk-scores-and-hallucinations-in-parkinsons-disease-patients/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Patients with Essential Tremor Live Longer than their Relatives
  • Life expectancy with and without Parkinson’s disease in the general population
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley